Raiffeisen Bank International’s Vertex Pharmaceuticals VRTX Stock Holding History

Raiffeisen Bank International’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.6M	Sell	97,170 -4,265	-4%	-$1.89M	0.57%	42
2026 Q1	$45M	Sell	101,435 -11,210	-10%	-$5.23M	0.65%	37
2025 Q4	$51.1M	Buy	112,645 +54	+0%	+$23.3K	0.66%	38
2025 Q3	$44.5M	Sell	112,591 -1,336	-1%	-$558K	0.59%	47
2025 Q2	$50.8M	Sell	113,927 -17,682	-13%	-$8.15M	0.75%	39
2025 Q1	$64.8M	Sell	131,609 -2,289	-2%	-$1.07M	1.03%	23
2024 Q4	$53.5M	Buy	+133,898	New	+$62.1M	0.81%	33

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Raiffeisen Bank International's VRTX Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Vertex Pharmaceuticals (VRTX) stake by 4.2% in Q2 2026, selling an estimated $1.89M and leaving 97,170 shares worth $48.6M. The position accounts for 0.57% of the portfolio, ranked #42.

Raiffeisen Bank International first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $64.8M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Raiffeisen Bank International held 97,170 shares of Vertex Pharmaceuticals worth $48.6M as of Q2 2026.
Raiffeisen Bank International sold 4,265 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.89M.
Vertex Pharmaceuticals made up 0.57% of Raiffeisen Bank International's portfolio in Q2 2026, its #42 holding.
Raiffeisen Bank International first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Raiffeisen Bank International's Vertex Pharmaceuticals position peaked at $64.8M in Q1 2025.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.